AIX-EN-PROVENCE, France, Jul 09, 2012 (BUSINESS WIRE) —
SuperSonic Imagine, the innovative ultrasound imaging company, today
announced that it has been selected by the Mid-Atlantic Group Network of
Shared Services (MAGNET) to provide its Participating Healthcare
Facilities with the most advanced ultrasound technology on the market.
MAGNET was created to develop contracts on behalf of its Healthcare
Facilities in the niche market of capital equipment to provide the best
quality patient care at the best possible pricing.
“We are extremely pleased to have this three year agreement in place
with SuperSonic Imagine to offer the Aixplorer(R) MultiWave(TM) Ultrasound
system to our Participating Healthcare Facilities,” said Steven R. Duke,
Vice President and Chief Operating Officer for MAGNET. “SuperSonic
Imagine has a strong reputation for being an ultrasound industry leader
and innovator, that brings important, clinically focused imaging
solutions to healthcare providers. Their revolutionary software-based
ultrasound imaging system has a wide range of clinical applications
which bring the greatest utility for MAGNET Participating Healthcare
Facilities.”
On the market since 2009, the Aixplorer MultiWave Ultrasound System’s
clinical applications include Vascular, Breast and 3D Breast, Abdomen,
Liver, Thyroid, Musculoskeletal, Gynecology, and Prostate. The system is
in a class of its own with a software-based architecture that industry
analysts believe has ushered in a new era in ultrasound imaging. No
longer held back by hardware constraints, an ultra-fast software
platform gives the Aixplorer the capability of visualizing fine detail
never seen before. Aside from exceptional gray scale quality, the
foundation of ultrasound imaging, Aixplorer offers true innovation not
found on conventional systems. The first major breakthrough born of this
ultra-rapid software is ShearWave(TM) Elastography, which reveals local,
real-time true tissue stiffness in a reproducible, user-skill
independent manner. This technology, clinically proven through a
rigorous multi-center global study, uses the combination of shear waves
and ultrasound waves to image tissue elasticity, a technique never
before possible due to hardware limitations. The second major innovation
made possible through its ultra-fast platform, is UltraFast(TM) Doppler, a
mode that combines Color Flow Imaging with Pulsed Wave Doppler. Workflow
and diagnostic confidence are significantly improved with blood flow
data clips that render extremely quick color frame rates (up to 200Hz),
high quality flow information without compromises and full spectral
Doppler analysis with multiple sample volumes instantly.
“MAGNET’s drive to provide the best quality for the best price has
always been our goal as well at SuperSonic Imagine,” said CEO Jacques
Souquet. “We are happy to be a part of the MAGNET network and to furnish
their Participating Healthcare Facilities with ultrasound technology
that provides extremely clear image quality with unprecedented
innovation to address their clinical challenges.”
About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic
Imagine is an innovative, international company specializing in
ultrasound medical imaging. The company designs, develops and markets a
revolutionary ultrasound system, Aixplorer(R), with a unique
ultrasound imaging technology, called MultiWave(TM) Technology. This
technology allows Aixplorer(R) to be the only ultrasound system
that images two types of waves to better characterize tissue; an
ultrasound wave to ensure impeccable image quality and a shear wave,
ShearWave(TM) Elastography, to compute and display true tissue stiffness in
real time by acquiring images nearly 200 times faster than conventional
systems.
ShearWave(TM) Elastography and UltraFast(TM) Doppler made possible by
Aixplorer’s software technology, allow physicians to visualize and
analyze in real-time, thanks to a reliable, reproducible and extremely
rapid process, the stiffness and vascularization of tissue in order to
significantly improve the detection and characterization of numerous
pathologies. The company has developed many clinical applications,
including for the breast, thyroid, liver and prostate. In 2009,
SuperSonic Imagine was granted 510(k) clearance by the Food and Drug
Administration in the United States and CE mark in Europe for the
marketing of Aixplorer(R). SuperSonic Imagine has an installed
base of 383 Aixplorersin over 50 countries as of March 31,
2012.
Distribution agreements have been signed with prestigious companies such
as Hologic
/quotes/zigman/73386/quotes/nls/holx HOLX
-0.55%
for the breast market in the U.S.A. and Canon
/quotes/zigman/192225/quotes/nls/caj CAJ
-1.21%
for Japan.
SuperSonic Imagine holds the exclusive right, title and interest to 28
international patents and submissions in diagnostic imaging and therapy
applications.
For more information about SuperSonic Imagine, please go to
www.supersonicimagine.com .
SOURCE: SuperSonic Imagine
SuperSonic Imagine
Michele Debain, M.B.A.
Global Marketing Director
+33 442 99 24 32
Michele.debain@supersonicimagine.fr
or
Beacon Communications
Dan Conley, 312-593-8461
dconley@beaconpr.com
Copyright Business Wire 2012
/quotes/zigman/73386/quotes/nls/holx
Add to portfolio
HOLX
/quotes/zigman/192225/quotes/nls/caj
Add to portfolio
CAJ
